Resverlogix Corp. (TSE:RVX – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.05 and traded as low as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 3,000 shares trading hands.
Resverlogix Trading Down 10.0 %
The company has a current ratio of 0.13, a quick ratio of 0.04 and a debt-to-equity ratio of -10.95. The business has a 50 day simple moving average of C$0.05 and a two-hundred day simple moving average of C$0.06. The stock has a market cap of C$8.91 million, a price-to-earnings ratio of -2.23 and a beta of 0.71.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- What is MarketRank™? How to Use it
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Breakout Stocks: What They Are and How to Identify Them
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
